Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000950103-18-013357
Filing Date
2018-11-14
Accepted
2018-11-14 06:01:14
Documents
1
Group Members
DONGLIANG LINFEI YANGHE XIE AI QI INVESTMENT MANAGEMENT (BEIJING) CO., LTD.HUGO SHONGJIANGUANG LISNOW MOON LTDTIANJIN JINGRAN MANAGEMENT CENTER (LIMITED PARTNERSHIP)

Document Format Files

Seq Description Document Type Size
1 FORM SC 13D/A dp98328_sc13da3.htm SC 13D/A 160271
  Complete submission text file 0000950103-18-013357.txt   162229
Mailing Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850
Business Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850 240-864-2600
CASI Pharmaceuticals, Inc. (Subject) CIK: 0000895051 (see all company filings)

EIN.: 581959440 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-46247 | Film No.: 181180140
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address P.O. BOX 957 OFFSHORE INCORPORATIONS CENTRE ROAD TOWN TORTOLA D8 00000
Business Address P.O. BOX 957 OFFSHORE INCORPORATIONS CENTRE ROAD TOWN TORTOLA D8 00000 852 2127 4863
SPARKLE BYTE LTD (Filed by) CIK: 0001663831 (see all company filings)

EIN.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 1231
Type: SC 13D/A